The pharmaceutical industry continually seeks novel and efficient chemical synthesis routes to produce complex drug molecules. Traditional synthetic pathways often require multiple steps, leading to low outputs and increased costs. To address these obstacles, researchers are examining innovative strategies, such as organocatalysis, to develop more